5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 1,621.80▲ | 1,643.32▼ |
MA10 | N/A | N/A | N/A | 1,622.55▲ | 1,656.02▼ |
MA20 | N/A | N/A | N/A | 1,638.91▼ | 1,602.08▲ |
MA50 | N/A | N/A | N/A | 1,658.94▼ | 1,487.87▲ |
MA100 | N/A | N/A | N/A | 1,590.68▲ | 1,483.00▲ |
MA200 | N/A | N/A | N/A | 1,505.92▲ | 1,479.66▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | 1.316▲ | -6.491▼ |
RSI | N/A | N/A | N/A | 49.296▼ | 57.126▲ |
STOCH | N/A | N/A | N/A | 51.150 | 50.872 |
WILL %R | N/A | N/A | N/A | -29.480 | -40.878 |
CCI | N/A | N/A | N/A | 96.684 | -15.786 |
Wednesday, April 24, 2024 01:14 AM
(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jemperli, when used in combination with chemotherapy.
|
Tuesday, April 23, 2024 11:44 PM
New drugs should significantly boost this FTSE stock’s earnings in my view. But even without them it looked very undervalued to me. The post Is this FTSE growth superstar set to soar even higher on ...
|
Tuesday, April 23, 2024 10:25 PM
Allen, currently CFO at British food ingredients maker Tate & Lyle (LON: TATE ), replaces Tobias Hestler, who has informed the Haleon board that he will step down as CFO.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
24/04/24 | 1,656.50 | 1,661.50 | 1,635.50 | 1,636.00 | 3,466,006 |
23/04/24 | 1,650.50 | 1,656.00 | 1,636.9961 | 1,651.00 | 3,326,665 |
22/04/24 | 1,618.00 | 1,647.50 | 1,610.50 | 1,639.50 | 6,191,667 |
19/04/24 | 1,579.50 | 1,600.00 | 1,575.00 | 1,599.00 | 3,760,947 |
18/04/24 | 1,593.00 | 1,600.24 | 1,580.00 | 1,583.50 | 3,346,064 |
17/04/24 | 1,598.00 | 1,603.00 | 1,576.50 | 1,590.00 | 6,002,987 |
16/04/24 | 1,626.50 | 1,627.3755 | 1,594.50 | 1,610.50 | 5,915,558 |
15/04/24 | 1,638.50 | 1,648.00 | 1,631.00 | 1,643.50 | 3,213,854 |
12/04/24 | 1,631.50 | 1,651.75 | 1,629.00 | 1,643.50 | 4,346,402 |
11/04/24 | 1,618.50 | 1,642.00 | 1,617.50 | 1,629.00 | 5,212,659 |
|
|
||||
|
|
||||
|
|